Published in Biomaterials on August 15, 2007
The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination. Tissue Eng Part B Rev (2009) 1.37
Tissue-engineered three-dimensional in vitro models for normal and diseased kidney. Tissue Eng Part A (2010) 1.09
Beta1-integrin is required for kidney collecting duct morphogenesis and maintenance of renal function. Am J Physiol Renal Physiol (2009) 1.07
Stiffness and adhesivity control aortic valve interstitial cell behavior within hyaluronic acid based hydrogels. Acta Biomater (2013) 1.02
A novel, low-volume method for organ culture of embryonic kidneys that allows development of cortico-medullary anatomical organization. PLoS One (2010) 0.95
Constructing kidney-like tissues from cells based on programs for organ development: toward a method of in vitro tissue engineering of the kidney. Tissue Eng Part A (2010) 0.95
Hyaluronan - a functional and structural sweet spot in the tissue microenvironment. Front Immunol (2015) 0.93
A protein kinase A and Wnt-dependent network regulating an intermediate stage in epithelial tubulogenesis during kidney development. Dev Biol (2012) 0.88
Organic anion and cation SLC22 "drug" transporter (Oat1, Oat3, and Oct1) regulation during development and maturation of the kidney proximal tubule. PLoS One (2012) 0.84
Correlation between hyaluronic acid,hyaluronic Acid synthase and human renal clear cell carcinoma. Chin J Cancer Res (2011) 0.75
Is regenerative medicine a new hope for kidney replacement? J Artif Organs (2014) 0.75
Special Morphological Features at the Interface of the Renal Stem/Progenitor Cell Niche Force to Reinvestigate Transport of Morphogens During Nephron Induction. Biores Open Access (2016) 0.75
Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. Biochemistry (1982) 6.87
Hyaluronan. FASEB J (1992) 6.67
Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 3.65
Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules (2005) 3.44
Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem (1999) 3.34
Candidate tumor suppressor HYAL2 is a glycosylphosphatidylinositol (GPI)-anchored cell-surface receptor for jaagsiekte sheep retrovirus, the envelope protein of which mediates oncogenic transformation. Proc Natl Acad Sci U S A (2001) 2.94
Early organogenesis of the kidney. Pediatr Nephrol (1987) 2.60
The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol (2001) 2.37
Mesenchymal to epithelial conversion in rat metanephros is induced by LIF. Cell (1999) 2.04
HYAL2, a human gene expressed in many cells, encodes a lysosomal hyaluronidase with a novel type of specificity. J Biol Chem (1998) 2.00
Human and porcine early kidney precursors as a new source for transplantation. Nat Med (2002) 1.73
Morphometric index of the developing murine kidney. Dev Dyn (2004) 1.70
Perspectives in organ preservation. Transplantation (2007) 1.63
TGF-beta superfamily members modulate growth, branching, shaping, and patterning of the ureteric bud. Dev Biol (2004) 1.59
TGF beta 2, LIF and FGF2 cooperate to induce nephrogenesis. Development (2001) 1.59
Review. Hyaluronan: a powerful tissue engineering tool. Tissue Eng (2006) 1.54
Differential expression and function of cadherin-6 during renal epithelium development. Development (1998) 1.53
Changes in global gene expression patterns during development and maturation of the rat kidney. Proc Natl Acad Sci U S A (2001) 1.48
Transplantation of developing metanephroi into adult rats. Kidney Int (1998) 1.33
Hyaluronic acid fillers. Dermatol Ther (2006) 1.32
Branching morphogenesis independent of mesenchymal-epithelial contact in the developing kidney. Proc Natl Acad Sci U S A (1999) 1.27
Hyaluronic acid fillers in facial rejuvenation. Semin Cutan Med Surg (2006) 1.17
Type VI collagen microfibrils: evidence for a structural association with hyaluronan. J Cell Biol (1992) 1.15
Biocompatibility and stability of disulfide-crosslinked hyaluronan films. Biomaterials (2005) 1.15
The retention and ultrastructural appearances of various extracellular matrix molecules incorporated into three-dimensional hydrated collagen lattices. Dev Biol (1985) 1.14
Hylan gel biomaterial: dermal and immunologic compatibility. J Biomed Mater Res (1993) 1.14
Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models. Kidney Int (2006) 1.13
Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Bioconjug Chem (1997) 1.10
Involvement of laminin binding integrins and laminin-5 in branching morphogenesis of the ureteric bud during kidney development. Dev Biol (2001) 1.09
Localization of Tamm-Horsfall glycoprotein in the human kidney using immuno-fluorescence and immuno-electron microscopical techniques. J Anat (1981) 1.09
Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney. Dev Biol (2004) 1.05
Identification of pleiotrophin as a mesenchymal factor involved in ureteric bud branching morphogenesis. Development (2001) 1.03
Interaction of intact type VI collagen with hyaluronan. FEBS Lett (1991) 1.01
Hyaluronan: genetic insights into the complex biology of a simple polysaccharide. Glycoconj J (2003) 1.00
Viscosupplementation for treatment of osteoarthritis: from initial discovery to current status and results. Surg Technol Int (2004) 0.97
A strategy for in vitro propagation of rat nephrons. Kidney Int (2002) 0.96
Role of hyaluronan and CD44 in in vitro branching morphogenesis of ureteric bud cells. Dev Biol (2000) 0.95
Crosslinking of hyaluronic acid with water-soluble carbodiimide. J Biomed Mater Res (1997) 0.94
Developmental approaches to kidney tissue engineering. Am J Physiol Renal Physiol (2004) 0.93
Heregulin induces glial cell line-derived neurotrophic growth factor-independent, non-branching growth and differentiation of ureteric bud epithelia. J Biol Chem (2005) 0.93
Quantitation of aquaporin-2 abundance in microdissected collecting ducts: axial distribution and control by AVP. Am J Physiol (1996) 0.93
Binding of hyaluronan to plasma fibronectin increases the attachment of corneal epithelial cells to a fibronectin matrix. J Cell Physiol (1994) 0.88
Ovine AQP1: cDNA cloning, ontogeny, and control of renal gene expression. Pediatr Nephrol (1998) 0.85
Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis. Am J Physiol Renal Physiol (2000) 0.85
Injectable hyaluronic acid implant for malar and mental enhancement. Dermatol Surg (2006) 0.85
Non-immunogenicity of purified hyaluronic acid preparations tested by passive cutaneous anaphylaxis. Int Arch Allergy Appl Immunol (1974) 0.81
Non-immunogenicity of a purified sodium hyaluronate preparation in man. Int Arch Allergy Appl Immunol (1979) 0.80
Effect of hyaluronic acid on development of in vitro produced bovine embryos. Theriogenology (1998) 0.79
Exogenous hyaluronic acid enhances porcine parthenogenetic embryo development in vitro possibly mediated by CD44. Theriogenology (2005) 0.78
Immunostaining of a heterodimeric dermatan sulphate proteoglycan is correlated with smooth muscles and some basement membranes. Histochem Cell Biol (1995) 0.76
Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature (2003) 3.72
Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knock-out mice. J Biol Chem (2005) 2.07
Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 (Slc22a8)) knockout mice. J Biol Chem (2002) 1.87
Impaired Wnt-beta-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy. Nat Med (2009) 1.86
TGF-beta superfamily members modulate growth, branching, shaping, and patterning of the ureteric bud. Dev Biol (2004) 1.59
Toward a systems level understanding of organic anion and other multispecific drug transporters: a remote sensing and signaling hypothesis. Mol Pharmacol (2009) 1.56
Branching morphogenesis and kidney disease. Development (2004) 1.54
Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics (2008) 1.53
Spatiotemporal regulation of morphogenetic molecules during in vitro branching of the isolated ureteric bud: toward a model of branching through budding in the developing kidney. Dev Biol (2004) 1.49
Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease. J Am Soc Nephrol (2013) 1.49
Adult kidney tubular cell population showing phenotypic plasticity, tubulogenic capacity, and integration capability into developing kidney. J Am Soc Nephrol (2005) 1.46
Multi-level analysis of organic anion transporters 1, 3, and 6 reveals major differences in structural determinants of antiviral discrimination. J Biol Chem (2008) 1.38
The molecular pharmacology of organic anion transporters: from DNA to FDA? Mol Pharmacol (2004) 1.25
Changes in gene expression patterns in the ureteric bud and metanephric mesenchyme in models of kidney development. Kidney Int (2003) 1.23
Identification of a novel murine organic anion transporter family member, OAT6, expressed in olfactory mucosa. Biochem Biophys Res Commun (2004) 1.22
Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members. J Biol Chem (2007) 1.22
Untargeted metabolomics identifies enterobiome metabolites and putative uremic toxins as substrates of organic anion transporter 1 (Oat1). J Proteome Res (2011) 1.18
Remote communication through solute carriers and ATP binding cassette drug transporter pathways: an update on the remote sensing and signaling hypothesis. Mol Pharmacol (2011) 1.16
Glial cell-derived neurotrophic factor independent ureteric bud outgrowth from the Wolffian duct. J Am Soc Nephrol (2007) 1.14
Organic anion transporter 3 contributes to the regulation of blood pressure. J Am Soc Nephrol (2008) 1.14
Novel slc22 transporter homologs in fly, worm, and human clarify the phylogeny of organic anion and cation transporters. Physiol Genomics (2004) 1.10
Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. Am J Physiol Renal Physiol (2008) 1.10
Rho kinase acts at separate steps in ureteric bud and metanephric mesenchyme morphogenesis during kidney development. Differentiation (2006) 1.08
Beta1-integrin is required for kidney collecting duct morphogenesis and maintenance of renal function. Am J Physiol Renal Physiol (2009) 1.07
Olfactory mucosa-expressed organic anion transporter, Oat6, manifests high affinity interactions with odorant organic anions. Biochem Biophys Res Commun (2006) 1.06
Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling. J Biol Chem (2010) 1.06
Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney. Dev Biol (2004) 1.05
Toward an etiological classification of developmental disorders of the kidney and upper urinary tract. Kidney Int (2002) 1.04
Analysis of metagene portraits reveals distinct transitions during kidney organogenesis. Sci Signal (2008) 1.03
A role for the organic anion transporter OAT3 in renal creatinine secretion in mice. Am J Physiol Renal Physiol (2012) 1.02
Implications of gene networks for understanding resilience and vulnerability in the kidney branching program. Physiology (Bethesda) (2004) 1.01
Interaction of organic cations with organic anion transporters. J Biol Chem (2009) 1.01
Organic anion and cation transporters occur in pairs of similar and similarly expressed genes. Biochem Biophys Res Commun (2003) 1.01
Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice. Am J Physiol Renal Physiol (2003) 0.99
A strategy for in vitro propagation of rat nephrons. Kidney Int (2002) 0.96
Activin A is an endogenous inhibitor of ureteric bud outgrowth from the Wolffian duct. Dev Biol (2006) 0.95
Constructing kidney-like tissues from cells based on programs for organ development: toward a method of in vitro tissue engineering of the kidney. Tissue Eng Part A (2010) 0.95
MAPAS: a tool for predicting membrane-contacting protein surfaces. Nat Methods (2008) 0.94
Hs2st mediated kidney mesenchyme induction regulates early ureteric bud branching. Dev Biol (2010) 0.94
Analysis of a large cluster of SLC22 transporter genes, including novel USTs, reveals species-specific amplification of subsets of family members. Physiol Genomics (2009) 0.93
Novel human cDNAs homologous to Drosophila Orct and mammalian carnitine transporters. Biochem Biophys Res Commun (2002) 0.93
Heregulin induces glial cell line-derived neurotrophic growth factor-independent, non-branching growth and differentiation of ureteric bud epithelia. J Biol Chem (2005) 0.93
Developmental approaches to kidney tissue engineering. Am J Physiol Renal Physiol (2004) 0.93
Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling. Dev Biol (2011) 0.93
The developmental nephrome: systems biology in the developing kidney. Curr Opin Nephrol Hypertens (2007) 0.92
Novel aspects of renal organic anion transporters. Curr Opin Nephrol Hypertens (2003) 0.91
Linkage of organic anion transporter-1 to metabolic pathways through integrated "omics"-driven network and functional analysis. J Biol Chem (2011) 0.91
Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)]. Kidney Int (2005) 0.91
Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice. PLoS One (2010) 0.90
The instructive role of metanephric mesenchyme in ureteric bud patterning, sculpting, and maturation and its potential ability to buffer ureteric bud branching defects. Am J Physiol Renal Physiol (2009) 0.90
Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney. Mol Pharmacol (2011) 0.89
Deletion of multispecific organic anion transporter Oat1/Slc22a6 protects against mercury-induced kidney injury. J Biol Chem (2011) 0.88
Growth factor-dependent branching of the ureteric bud is modulated by selective 6-O sulfation of heparan sulfate. Dev Biol (2011) 0.88
Development and differentiation of the ureteric bud into the ureter in the absence of a kidney collecting system. Dev Biol (2006) 0.88
A protein kinase A and Wnt-dependent network regulating an intermediate stage in epithelial tubulogenesis during kidney development. Dev Biol (2012) 0.88
Hepatocyte nuclear factors 4α and 1α regulate kidney developmental expression of drug-metabolizing enzymes and drug transporters. Mol Pharmacol (2013) 0.85
Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue. Neurosci Lett (2012) 0.84
Organic anion and cation SLC22 "drug" transporter (Oat1, Oat3, and Oct1) regulation during development and maturation of the kidney proximal tubule. PLoS One (2012) 0.84
Relevance of ureteric bud development and branching to tissue engineering, regeneration and repair in acute and chronic kidney disease. Curr Opin Organ Transplant (2014) 0.83
Protein kinase A regulates GDNF/RET-dependent but not GDNF/Ret-independent ureteric bud outgrowth from the Wolffian duct. Dev Biol (2010) 0.83
Biochemical processing of E-cadherin under cellular stress. Biochem Biophys Res Commun (2003) 0.83
Multispecific drug transporter Slc22a8 (Oat3) regulates multiple metabolic and signaling pathways. Drug Metab Dispos (2013) 0.83
Modeling of glycerol-3-phosphate transporter suggests a potential 'tilt' mechanism involved in its function. J Bioinform Comput Biol (2008) 0.82
Neuropeptide Y functions as a facilitator of GDNF-induced budding of the Wolffian duct. Development (2009) 0.81
Tunicamycin preserves intercellular junctions, cytoarchitecture, and cell-substratum interactions in ATP-depleted epithelial cells. Biochem Biophys Res Commun (2004) 0.80
Elucidation of common pharmacophores from analysis of targeted metabolites transported by the multispecific drug transporter-Organic anion transporter1 (Oat1). Bioorg Med Chem (2011) 0.80
N-sulfation of heparan sulfate regulates early branching events in the developing mammary gland. J Biol Chem (2012) 0.80
Analyses of 5' regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3). J Hum Genet (2006) 0.79
Conformational changes of the multispecific transporter organic anion transporter 1 (OAT1/SLC22A6) suggests a molecular mechanism for initial stages of drug and metabolite transport. Cell Biochem Biophys (2011) 0.79
Cellular and developmental strategies aimed at kidney tissue engineering. Nephron Exp Nephrol (2014) 0.79
From the ureteric bud to the penome. Kidney Int (2003) 0.78
In vitro culture of embryonic kidney rudiments and isolated ureteric buds. Methods Mol Biol (2012) 0.78
Complex dynamics of chaperone-protein interactions under cellular stress. Cell Biochem Biophys (2004) 0.77
Debt91, a putative zinc finger protein differentially expressed during epithelial morphogenesis. Biochem Biophys Res Commun (2003) 0.77
GDNF-independent ureteric budding: role of PI3K-independent activation of AKT and FOSB/JUN/AP-1 signaling. Biol Open (2013) 0.76
Branching morphogenesis: from individual molecules to a systems biology approach: commentary on "Sema4C-Plexin B2 signalling modulates ureteric branching in developing kidney" by Perälä et al. Differentiation (2010) 0.75